title: New perspectives and directions in schizophrenia therapeutics: advances related to non-dopaminergic systems.
authors.forename: Saleem
authors.initials: S
authors.lastname: Al-Nuaimi
authors.forename: Cristiano
authors.initials: C
authors.lastname: Chaves
authors.forename: Jaime E C
authors.initials: JE
authors.lastname: Hallak
authors.forename: Glen B
authors.initials: GB
authors.lastname: Baker
authors.forename: Serdar
authors.initials: S
authors.lastname: Dursun
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D011978:Receptors, Nicotinic / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011978:Receptors, Nicotinic; D004298:Dopamine